Tempus AI, Inc. $TEM Shares Acquired by IQ EQ FUND MANAGEMENT IRELAND Ltd

IQ EQ FUND MANAGEMENT IRELAND Ltd lifted its stake in shares of Tempus AI, Inc. (NASDAQ:TEM) by 125.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 114,373 shares of the company’s stock after buying an additional 63,707 shares during the quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd owned about 0.07% of Tempus AI worth $7,267,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Concord Wealth Partners lifted its stake in Tempus AI by 308.0% in the second quarter. Concord Wealth Partners now owns 408 shares of the company’s stock valued at $26,000 after buying an additional 308 shares during the last quarter. University of Texas Texas AM Investment Management Co. acquired a new stake in shares of Tempus AI in the 1st quarter valued at approximately $33,000. Bartlett & CO. Wealth Management LLC boosted its position in shares of Tempus AI by 100.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company’s stock worth $39,000 after purchasing an additional 400 shares in the last quarter. Nemes Rush Group LLC purchased a new stake in Tempus AI during the first quarter worth about $39,000. Finally, Quarry LP purchased a new stake in shares of Tempus AI during the 1st quarter worth approximately $44,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on TEM shares. HC Wainwright increased their price objective on shares of Tempus AI from $90.00 to $98.00 and gave the company a “buy” rating in a research note on Friday, September 12th. Needham & Company LLC reaffirmed a “buy” rating and issued a $70.00 price objective on shares of Tempus AI in a research report on Friday, August 8th. TD Cowen downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 target price for the company. in a report on Tuesday, October 21st. Canaccord Genuity Group initiated coverage on Tempus AI in a research note on Monday, October 20th. They set a “buy” rating and a $110.00 price target for the company. Finally, Guggenheim raised their target price on shares of Tempus AI from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 26th. Seven investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $79.38.

Tempus AI Trading Up 2.6%

TEM opened at $91.58 on Tuesday. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43. Tempus AI, Inc. has a 12-month low of $31.36 and a 12-month high of $104.32. The firm’s fifty day moving average price is $84.46 and its 200 day moving average price is $68.38. The stock has a market capitalization of $15.91 billion, a PE ratio of -76.96 and a beta of 4.87.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. The business had revenue of $314.64 million during the quarter, compared to the consensus estimate of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company’s revenue for the quarter was up 89.5% compared to the same quarter last year. During the same period last year, the firm earned ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. As a group, research analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Eric P. Lefkofsky sold 332,500 shares of Tempus AI stock in a transaction dated Thursday, September 25th. The shares were sold at an average price of $76.56, for a total value of $25,456,200.00. Following the completion of the transaction, the chief executive officer directly owned 9,141,032 shares of the company’s stock, valued at approximately $699,837,409.92. The trade was a 3.51% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, COO Ryan Fukushima sold 17,460 shares of Tempus AI stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $1,303,389.00. Following the completion of the transaction, the chief operating officer owned 839,180 shares of the company’s stock, valued at approximately $62,644,787. The trade was a 2.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 767,412 shares of company stock worth $57,618,856. Corporate insiders own 26.27% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.